Jefferies Financial Group Inc. Halozyme Therapeutics, Inc. Transaction History
Jefferies Financial Group Inc.
- $10.7 Billion
- Q1 2025
A detailed history of Jefferies Financial Group Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 12,263 shares of HALO stock, worth $653,740. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,263Holding current value
$653,740% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$939 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$684 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$323 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$208 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$196 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.43B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...